Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Chinese Journal of Applied Physiology ; (6): 72-75, 2015.
Article Dans Chinois | WPRIM | ID: wpr-243429

Résumé

<p><b>OBJECTIVE</b>To explore the relationship between the expression of Survivin and Ki67 with prognosis of pancreatic endocrine tumors (PETs).</p><p><b>METHODS</b>Immunohistochemistry for Survivin and Ki67 was performed in 25 cases of normal pancreatic tissues and 81 cases of PETs by tissue microarrays and to observe the expression and evaluate the relationship with prognosis.</p><p><b>RESULTS</b>(1)The expression of Survivin and Ki67 in PETs was significantly higher than that in normal pancreatic tissues (P <0.01); (2)The expression of Survivin and Ki67 in PETs was correlated with tissue grading and the TNM-staging (P < 0.05), but not related with tumor size, location and functional status. In addition, the expression of nuclear Survivin was association with lymph node metastasis (P < 0.05). (3)The high expression of Ki67 was related with the expression of nuclear Survivin, but not related with the expression of cytoplasmic Survivin.</p><p><b>CONCLUSION</b>Survivin and Ki67 were both expressed in PETs, which were closely related to the clinical pathological characteristics. They could be used as new indicators in the evaluation of prognosis of PETs. The expression of Survivin in nucleus had more diagnostic significance than that in cytoplasm, and that could be highly correlated with lymph node metastasis, which would be used as a new marker of poor prognosis.</p>


Sujets)
Humains , Marqueurs biologiques tumoraux , Métabolisme , Noyau de la cellule , Métabolisme , Cytoplasme , Métabolisme , Immunohistochimie , Protéines IAP , Métabolisme , Antigène KI-67 , Métabolisme , Métastase lymphatique , Stadification tumorale , Tumeurs du pancréas , Diagnostic , Pronostic
2.
J Biosci ; 2008 Mar; 33(1): 55-62
Article Dans Anglais | IMSEAR | ID: sea-111221

Résumé

According to the method used in our laboratory,our group synthesized (DIPP-Trp)2-Lys-OCH 3. It inhibited the proliferation of K562 and HeLa cells in a dose-and time-dependent manner with an IC 50 of 15.12 and 42.23 microM, respectively. (DIPP-Trp) 2-Lys-OCH3 induced a dose-dependent increase of the G2/M cell population in K562 cells, and S cell population in HeLa cells;the sub-G0 population increased dramatically in both cell lines as seen by PI staining experiments using a FACS Calibur Flow cytometer (BeckmanCoulter,USA). Phosphatidylserine could signi?cantly translocate to the surface of the membrane in (DIPP-Trp)2-Lys-OCH3-treated K562 and HeLa cells.The increase of an early apoptotic population was observed in a dose-dependent manner by both annexin-FITC and PI staining.It was concluded that (DIPP-Trp) 2-Lys-OCH3 not only induced cells to enter into apoptosis,but also affected the progress of the cell cycle.It may have arrested the K562 and HeLa cells in the G 2/M,S phases,respectively.The apoptotic pathway was pulsed at this point,resulting in the treated cells entering into programmed cell death.(DIPP- Trp)-Lys-OCH is a potential anticancer drug that intervenes in the signalling pathway.


Sujets)
Annexines/métabolisme , Apoptose/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Cytométrie en flux , Fluorescéine-5-isothiocyanate/métabolisme , Colorants fluorescents/métabolisme , Phase G2/effets des médicaments et des substances chimiques , Cellules HeLa , Humains , Concentration inhibitrice 50 , Cellules K562 , Mitose/effets des médicaments et des substances chimiques , Structure moléculaire , Oligopeptides/synthèse chimique , Phosphopeptides/synthèse chimique , Phase S/effets des médicaments et des substances chimiques , Sels de tétrazolium/analyse , Thiazoles/analyse , Facteurs temps
SÉLECTION CITATIONS
Détails de la recherche